Glenmark Life Sciences to raise around Rs 1500 crore via IPO: Know how COVID impacted company’s demand

The subsidiary of pharma major Glenmark Pharmaceuticals, Glenmark Life Sciences, is expected to raise around Rs 1,500 crore through its initial public offering (IPO). The offer will open on July 27 …
( read original story …)


Search your Hotel